The Study of SRSF1 Regulates Abnormal Alternative Splicing of <i>BCL2L11</i> and the Role in Refractory Acute Myeloid Leukemia

Abnormalities in splicing factors, such as mutations or deregulated expression, can lead to aberrant splicing of target genes, potentially contributing to the pathogenesis of acute myeloid leukemia (AML). Despite this, the precise mechanism underlying the abnormal alternative splicing (AS) induced by SRSF1, a splicing factor associated with poor AML prognosis, remains elusive.